ArticleScientific reports2025
Thyroid function and multiple sclerosis: a two-sample mendelian randomization study and mediation analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identifying Risk Factors for the Rising Prevalence of Multiple Sclerosis in Saudi Arabia: A case-control analysis.Neurosciences (Riyadh, Saudi Arabia) · 2026Article
- Global research trends on thyroid hormones and neurodegenerative diseases: a bibliometric study from 2015 to 2025.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) is a prevalent neurological disorder with a complex etiology, often associated with thyroid function. However, the causal relationship between these two conditions remains poorly understood. This study aimed to elucidate the causal relationship between thyroid function and MS using a bidirectional Mendelian randomization (MR) approach and to investigate the potential mediating role of immune cells. We conducted a two-sample MR analysis using summary statistics from large-scale genome-wide association studies (GWAS). We included results from sensitivity tests such as MR-Egger, weighted median, and leave-one-out analyses to support the robustness and reliability of the findings. The inverse variance-weighted (IVW) method was the primary approach, with sensitivity analyses conducted using seven additional MR methods. Furthermore, multivariable MR and mediation analysis were conducted to uncover potential mediating immune cells underlying the observed associations. The MR analysis showed that Hypothyroidism and elevated Thyroid-Stimulating Hormone (TSH) levels(normal) reduced the risk of MS (P = 0.012, OR (95%CI) :0.914(0.851, 0.98); P = 0.020, OR (95%CI) :0.88(0.789, 0.98)). Free thyroxine (FT4) increased the risk of MS (P = 0.020, OR (95%CI) :1.268(1.051, 1.53)). Mediation analysis showed evidence of indirect effect of FT4 on MS through "HLA DR on CD33br HLA DR + CD14" and "IgD- CD27- %B cell" with a mediated proportion of 39.16% (positive effect), 78.53% (reverse effect) of the total effect. This study provided genetic evidence that FT4 may increase the risk of developing MS. "HLA DR on CD33br HLA DR + CD14" and "IgD- CD27- %B cell", mediated the causal relationship between thyroid function and MS, highlighting the importance of further investigating their roles in these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.